Cite
Hepatitis C virus drug resistance associated substitutions and their clinical relevance: Update 2018.
MLA
Sorbo, Maria C., et al. “Hepatitis C Virus Drug Resistance Associated Substitutions and Their Clinical Relevance: Update 2018.” Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy, vol. 37, Mar. 2018, pp. 17–39. EBSCOhost, https://doi.org/10.1016/j.drup.2018.01.004.
APA
Sorbo, M. C., Cento, V., Di Maio, V. C., Howe, A. Y. M., Garcia, F., Perno, C. F., & Ceccherini-Silberstein, F. (2018). Hepatitis C virus drug resistance associated substitutions and their clinical relevance: Update 2018. Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy, 37, 17–39. https://doi.org/10.1016/j.drup.2018.01.004
Chicago
Sorbo, Maria C, Valeria Cento, Velia C Di Maio, Anita Y M Howe, Federico Garcia, Carlo F Perno, and Francesca Ceccherini-Silberstein. 2018. “Hepatitis C Virus Drug Resistance Associated Substitutions and Their Clinical Relevance: Update 2018.” Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy 37 (March): 17–39. doi:10.1016/j.drup.2018.01.004.